The neuropsychology of ecstasy (MDMA) use: A quantitative review

Human Psychopharmacology

Volumn 22, Issue 7, 2007, Pages 427-435

  Zakzanis, Konstantine K ^a   Campbell, Zachariah ^a   Jovanovski, Diana ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ecstasy; MDMA; Meta analysis; Neuropsychology; Review

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; RECREATIONAL DRUG;

ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONCENTRATION LOSS; DRUG DEPENDENCE; DRUG MISUSE; HUMAN; LEARNING DISORDER; MEMORY DISORDER; MENTAL DISEASE; MENTAL PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVIEW;

ATTENTION; COGNITION DISORDERS; HALLUCINOGENS; HUMANS; LEARNING; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 35349031067     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.873     Document Type: Review

References (71)

1. Back-Madruga C, Boone KB, Chang L, et al. 2003. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17: 446-459.
2. Bayen CA, Rosenberg H. 2006. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101: 933-947.
3. Bhattachary S, Powell JH. 2001. Recreational use of 3,4-methylenedioxymethammphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 31: 647-658.
4. Bolla KI, McCann UD, Ricaurte GA. 1998. Memory impairment in abstinent MDMA ('Ecstasy') users. Neurology 51: 1532-1537.
5. Cohen J. 1988. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Lawrence Erlbaum Associates: Hillsdale, NJ.
6. Cooper H, Hedges LV. 1994. The Handbook of Research Synthesis. Russel Sage Foundation: New York.
7. Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH. 2001. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153: 373-379.
8. Curran HV, Travill RA. 1997. Mood and cognitive effects of ± 3,4- methylenedioxymet hamphetamine (MDMA, 'ecstasy'): week- end 'high' followed by mid-week low. Addiction 92: 821-831.
9. Demakis GJ. 2006. Meta-analysis in neuropsychology: basic approaches, findings, and applications. Clin Neuropsychol 20: 10-26.
10. Fisk JE, Montgomery C, Murphy P, Wareing M. 2004. Evidence for executive deficits among users in MDMA (Ecstasy). Br J Psychol 95: 457-466.
11. Fox HC, Parrott AC, Tumer JD. 2001. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol 15: 273-281.
12. Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ. 2002. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ('ecstasy') polydrug users. Psychopharmacology 162: 203-214.
13. Gouzoulis-Mayfrank E, Daumann J. 2006. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 20: 188-193.
14. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, et al. 2000. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatr 68: 719-725.
15. Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J. 2003. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 27: 819-827.
16. Halpern JH, Pope HG, Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. 2004. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75: 135-147.
17. Hanson KL, Luciana M. 2004. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychol Med 34: 229-246.
18. Hedges LV, Olkin I. 1985. Statistical Methods for Meta-Analysis. Academic Press: New York.
19. Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J. 2001. Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Hum Psychopharmacol 16: 607-612.
20. Hunter JE, Schmidt FL. 1990. Methods of Meta-Analysis. Sage Publications: Newbury Park, CA.
21. Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF. 2007. MDMA use and neurocognition: a meta-analytical review. Psychopharmacology 189: 531-537.
22. Klugman A, Gruzelier J. 2003. Chronic cognitive impairment in users of 'ecstasy' and cannabis. World Psychiatry 2: 184-190.
23. Klugman A, Hardy S, Baldeweg T, Gruzelier J. 1999. Toxic effect of MDMA on brain serotonin neurons. Lancet 353: 1269-1270.
24. Kouimtsidis C, Schifano F, Sharp T, Ford L, Robinson J, Magee C. 2006. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets. Psychosomatics 47: 86-87.
25. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR. 1992. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?. Am J Drug AIcohol Abuse 18: 331-341.
26. Lamers CT, Ramaekers JG, Muntjewerff ND, et al. 2003. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17: 379-387.
27. Lamers CT, Bechara A, Rizzo M, Ramaekers JG. 2006. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol 20: 302-311.
28. Lezak MD, Howieson DB, Loring DW. 2004. Neuropsychological Assessment (4th edn). Oxford University Press: New York.
29. Lipsey MW, Wilson DB. 2000. Practical Meta-Analysis. Sage Publications: Thousand Oaks, CA.
30. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA. 1999. Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users: a controlled study. Psychopharmacology 143: 417-425.
31. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C. 2004. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173: 434-439.
32. McGuire P. 2000. Long term psychiatric and cognitive effects of MDMA use. Toxicol Lett 112-113: 153-156.
33. Medina KL, Shear PK, Corcoran K. 2005. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective. J Int Neuropsychol Soc 11: 753-765.
34. Montgomery C, Fisk JE, Newcombe R, Murphy PN. 2005a. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 182: 262-276.
35. Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN. 2005b. Syllogistic reasoning performance in MDMA (Ecstasy) users. Exp Clin Psychopharmacol 13: 137-145.
36. Morgan MJ. 1998. Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-264.
37. Morgan MJ. 1999. Memory deficits associated with recreational use of 'ecstasy' (MDMA). Psychopharmacology 141: 30-36.
38. Morgan MJ. 2000. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152: 230-248.
39. Orwin RG. 1983. A fail-safe N for effect size. J Ed Stat 8: 157-159.
40. Parrott AC. 2001. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16: 557-577.
41. Parrott AC. 2006. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 20: 147-163.
42. Parrott AC, Lasky J. 1998. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a saturday night dance. Psychopharmacology 139: 261-268.
43. Parrott AC, Lees A, Gamham NJ, Jones M, Wesnes K. 1998. Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits. J Psychopharmacol 12: 79-83.
44. Quednow BB, Kuhn KU, Hoppe C, et al. 2007. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ('Ecstasy'). Psychopharmacology 189: 517-530.
45. Reay JL, Hamilton C, Kennedy DO, Scholey AB. 2006. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol 20: 385-388.
46. Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. 2000. Memory disturbances in 'Ecstasy' users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148: 322-324.
47. Reneman L, Lavalaye J, Schmand B, et al. 2001a. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenediozymethamphetamine (MDMA or 'ecstasy'): preliminary findings. Arch Gen Psychiatry 58: 901-906.
48. Reneman L, Majoie CBLM, Schmand B, van den Brink W, den Heeten GJ. 2001b. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biol Psychiatry 50: 550-554.
49. Rodgers J. 2000. Cognitive performance amongst recreational users of 'ecstasy'. Psychopharmacology 151: 19-24.
50. Roiser JP, Rogers RD, Sahakian BJ. 2007. Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology 189: 505-516.
51. Rosentbal R. 1995. Writing meta-analytic reviews. Psychol Bull 118: 183-192.
52. Rosenthal R. 1991. Meta-analytic Procedures for Social Research. Sage Publications: Beverly Hills, CA.
53. Schifano F, Di-Furia L, Forza G, Minicuci M, Bricolo R. 1998. MDMA ('Ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52: 85-90.
54. Simon NG, Mattick RP. 2002. The impact of regular ecstasy use on memory function. Addiction 97: 1523-1529.
55. Smith RM, Tivarus M, Campbell HL, Hillier A, Beversdoff DQ. 2006. Apparent transient effects of recent 'ecstasy' use on cognitive performance and extrapyramidal signs in human subjects. Cogn Behav Neurol 19: 157-164.
56. Strauss E, Sherman EMS, Spreen O. 2006. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press: New York.
57. Thomasius R, Zapletalova P, Petersen K, et al. 2006. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20: 211-225.
58. Verbaten MN. 2003. Specific memory deficits in ecstasy users? The result of meta-analysis. Hum Psychopharmacol 18: 281-290.
59. Verkes RJ, Gijsman HJ, Pieters MS, et al. 2001. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153: 196-202.
60. Wareing M, Fisk JE, Murphy PN. 2000. Working memory deficits in current and previous users of MDMA ('ecstasy'). Br J Psychol 91: 181-188.
61. Wareing M, Fisk JE, Murphy P, Montgomery C. 2004a. Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol Clin Exp 19: 225-234.
62. Wareing M, Murphy PN, Fisk JE. 2004b. Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology 173: 391-397.
63. Wolf FM. 1986. Meta-Analysis: Quantitative Methods for Research Synthesis. Sage Publications: Newbury, CA.
64. Yip JT, Lee TM. 2005. Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179: 620-628.
65. Zakazanis KK, Leach L, Kaplan E. 1999. Neuropsychological Differential Diagnosis. Swets & Zeitlinger: Lisse, Netherlands.
66. Zakzanis KK. 1998. Brain is related to behavior (P < 0.05). J Clin Exp Neuropsychol 20: 419-427.
67. Zakzanis KK, Campbell Z. 2006. Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology 66: 740-741.
68. Zakzanis KK, Young DA. 2001a. Memory impairment in abstinent MDMA ('ecstasy') users: a longitudinal investigation. Neurology 56: 966-969.
69. Zakzanis KK, Young DA. 2001b. Executive function in abstinent MDMA ('ecstasy') users. Med Sci Monit 7: 1292-1298.
70. Zakzanis KK, Young DA, Radkhoshnoud NF. 2002. Attentional processes in abstinent methylenedioxymethamphetamine ('ecstasy') users. Appl Neuropsychol 9: 84-91.
71. Zakzanis KK, Young DA, Campbell Z. 2003. Prospective memory impairment in abstinent MDMA ('Ecstasy') users. Cognit Neuropsychiatry 8: 141-153.